Literature DB >> 22246955

Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes.

Diane C Munday1, Rebecca Surtees, Edward Emmott, Brian K Dove, Paul Digard, John N Barr, Adrian Whitehouse, David Matthews, Julian A Hiscox.   

Abstract

Viruses continue to pose some of the greatest threats to human and animal health, and food security worldwide. Therefore, new approaches are required to increase our understanding of virus-host cell interactions and subsequently design more effective therapeutic countermeasures. Quantitative proteomics based on stable isotope labeling by amino acids in cell culture (SILAC), coupled to LC-MS/MS and bioinformatic analysis, is providing an excellent resource for studying host cell proteomes and can readily be applied for the study of virus infection. Here, we review this approach and discuss how virus-host cell interactions can best be studied, what is realistically feasible, and the potential limitations. For example, sub-cellular fractionation can reduce sample complexity for LC-MS/MS, increase data return and provide information regarding protein trafficking between different cellular compartments. The key to successful quantitative proteomics combines good experimental design and appropriate sample preparation with statistical analysis and validation of the MS data through the use of independent techniques and functional analysis. The annotation of the human genome and the increasing availability of biological reagents such as antibodies, provide the optimum parameters for studying viruses that infect humans, in human cell lines. SILAC-based quantitative proteomics can also be used to study the interactome of viral proteins with the host cell. Coupling proteomic studies with global transcriptomic and RNA depletion experiments will provide great insights into the complexity of the infection process, and potentially reveal new antiviral targets.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246955     DOI: 10.1002/pmic.201100488

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  30 in total

1.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Cytotopic localization by long noncoding RNAs.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Curr Opin Cell Biol       Date:  2012-12-29       Impact factor: 8.382

3.  New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein.

Authors:  Sarit Kipper; Samar Hamad; Leon Caly; Dorit Avrahami; Eran Bacharach; David A Jans; Doron Gerber; Monika Bajorek
Journal:  Mol Cell Proteomics       Date:  2015-01-02       Impact factor: 5.911

4.  Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions.

Authors:  Yang Luo; Mark A Muesing
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

5.  An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins.

Authors:  Erik M Lenarcic; Benjamin J Ziehr; Nathaniel J Moorman
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

6.  A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection.

Authors:  Keyur A Dave; Emma L Norris; Alexander A Bukreyev; Madeleine J Headlam; Ursula J Buchholz; Toshna Singh; Peter L Collins; Jeffrey J Gorman
Journal:  Mol Cell Proteomics       Date:  2014-08-08       Impact factor: 5.911

7.  Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).

Authors:  Christopher B Owen; David J Hughes; Belinda Baquero-Perez; Anja Berndt; Sophie Schumann; Brian R Jackson; Adrian Whitehouse
Journal:  Mol Clin Oncol       Date:  2014-07-09

Review 8.  Discovering antiviral restriction factors and pathways using genetic screens.

Authors:  Chloe E Jones; Wenfang S Tan; Finn Grey; David J Hughes
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 3.891

9.  Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling.

Authors:  David A Griffiths; Hussein Abdul-Sada; Laura M Knight; Brian R Jackson; Kathryn Richards; Emma L Prescott; A Howard S Peach; G Eric Blair; Andrew Macdonald; Adrian Whitehouse
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

Authors:  Rong Hu; Xiaowei Wang; Xianquan Zhan
Journal:  EPMA J       Date:  2013-01-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.